BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12750264)

  • 1. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility.
    Fu YP; Yu JC; Cheng TC; Lou MA; Hsu GC; Wu CY; Chen ST; Wu HS; Wu PE; Shen CY
    Cancer Res; 2003 May; 63(10):2440-6. PubMed ID: 12750264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homologous recombination and nonhomologous end-joining repair pathways regulate fragile site stability.
    Schwartz M; Zlotorynski E; Goldberg M; Ozeri E; Rahat A; le Sage C; Chen BP; Chen DJ; Agami R; Kerem B
    Genes Dev; 2005 Nov; 19(22):2715-26. PubMed ID: 16291645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl2 negatively regulates DNA double-strand-break repair through a nonhomologous end-joining pathway.
    Wang Q; Gao F; May WS; Zhang Y; Flagg T; Deng X
    Mol Cell; 2008 Feb; 29(4):488-98. PubMed ID: 18313386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of nonhomologous DNA end joining varies among somatic tissues, despite similarity in mechanism.
    Sharma S; Choudhary B; Raghavan SC
    Cell Mol Life Sci; 2011 Feb; 68(4):661-76. PubMed ID: 20680388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Polymorphisms in DNA Damage Repair Pathway Genes and Female Breast Cancer Risk.
    Wang Y; Sun Y; Tan M; Lin X; Tai P; Huang X; Jin Q; Yuan D; Xu T; He B
    DNA Cell Biol; 2024 May; 43(5):219-231. PubMed ID: 38634815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth defect and mutator phenotypes of RecQ-deficient Neurospora crassa mutants separately result from homologous recombination and nonhomologous end joining during repair of DNA double-strand breaks.
    Kato A; Inoue H
    Genetics; 2006 Jan; 172(1):113-25. PubMed ID: 16219790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer through nonhomologous end-joining pathway.
    Lyu F; Huang S; Yan Z; He Q; Liu C; Cheng L; Cong Y; Chen K; Song Y; Xing Y
    Cell Signal; 2024 Jul; 119():111164. PubMed ID: 38583745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cGAS-Ku80 complex regulates the balance between two end joining subpathways.
    Zhang H; Jiang L; Du X; Qian Z; Wu G; Jiang Y; Mao Z
    Cell Death Differ; 2024 Apr; ():. PubMed ID: 38664591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association between Inefficient Repair of DNA Double-Strand Breaks and Common Polymorphisms of the HRR and NHEJ Repair Genes in Patients with Rheumatoid Arthritis.
    Galita G; Sarnik J; Brzezinska O; Budlewski T; Poplawska M; Sakowski S; Dudek G; Majsterek I; Makowska J; Poplawski T
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays.
    Sadeghi F; Asgari M; Matloubi M; Ranjbar M; Karkhaneh Yousefi N; Azari T; Zaki-Dizaji M
    Biol Proced Online; 2020; 22():23. PubMed ID: 33013205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do placental genes affect maternal breast cancer? Association between offspring's CGB5 and CSH1 gene variants and maternal breast cancer risk.
    Chen Y; Kibriya MG; Jasmine F; Santella RM; Senie RT; Ahsan H
    Cancer Res; 2008 Dec; 68(23):9729-34. PubMed ID: 19047151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variations in apoptosis pathway and the risk of ovarian cancer.
    Xie H; Tao W; Wu X; Gu J
    Oncotarget; 2016 Aug; 7(35):56737-56745. PubMed ID: 27462919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RUVBL1 ubiquitination by DTL promotes RUVBL1/2-β-catenin-mediated transcriptional regulation of NHEJ pathway and enhances radiation resistance in breast cancer.
    Tian J; Wen M; Gao P; Feng M; Wei G
    Cell Death Dis; 2024 Apr; 15(4):259. PubMed ID: 38609375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma.
    Dharanipragada P; Zhang X; Liu S; Lomeli SH; Hong A; Wang Y; Yang Z; Lo KZ; Vega-Crespo A; Ribas A; Moschos SJ; Moriceau G; Lo RS
    Cancer Discov; 2023 Apr; 13(4):880-909. PubMed ID: 36700848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary breast cancer: ever more pieces to the polygenic puzzle.
    Bogdanova N; Helbig S; Dörk T
    Hered Cancer Clin Pract; 2013 Sep; 11(1):12. PubMed ID: 24025454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational inference of cancer-specific vulnerabilities in clinical samples.
    Jang K; Park MJ; Park JS; Hwangbo H; Sung MK; Kim S; Jung J; Lee JW; Ahn SH; Chang S; Choi JK
    Genome Biol; 2020 Jun; 21(1):155. PubMed ID: 32600395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of BRCA1 in non-homologous end-joining.
    Bau DT; Mau YC; Shen CY
    Cancer Lett; 2006 Aug; 240(1):1-8. PubMed ID: 16171943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Contribution of DNA Ligase 4 Polymorphisms to Colorectal Cancer.
    Deng Y; Ke TW; Yueh TC; Chin YT; Wang YC; Hung YC; Mong MC; Yang YC; Wu WT; Chang WS; Gu J; Bau DT; Tsai CW
    In Vivo; 2024; 38(1):127-133. PubMed ID: 38148049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bulky glycocalyx shields cancer cells from invasion-associated stresses.
    Piplani N; Roy T; Saxena N; Sen S
    Transl Oncol; 2024 Jan; 39():101822. PubMed ID: 37931370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using machine learning to identify gene interaction networks associated with breast cancer.
    Liu L; Zhai W; Wang F; Yu L; Zhou F; Xiang Y; Huang S; Zheng C; Yuan Z; He Y; Yu Z; Ji J
    BMC Cancer; 2022 Oct; 22(1):1070. PubMed ID: 36253742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.